Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo

References

• Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers–liposomes and microspheres–on the phagocytosis by macrophages. J Control Release, 79, 29–40.
   PubMed Web of Science ®Google Scholar
• Chawla S, Kumar S, Garg M, Kumar R, Roy R, Gupta RK. (2004). Metabolite pattern of Cysticercus cellulosae metacestode from different predilection sites of swine using proton magnetic resonance spectroscopy. Parasite, 11, 161–167.
   PubMed Web of Science ®Google Scholar
• Chellat F, Merhi Y, Moreau A, Yahia L. (2005). Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials, 26, 7260–7275.
   PubMed Web of Science ®Google Scholar
• Chen CL, Wang YM, Liu CF, Wang JY. (2008). The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. Biomaterials, 29, 2173–2182.
   PubMed Web of Science ®Google Scholar
• Coester CJ, Langer K, van Briesen H, Kreuter J. (2000). Gelatin nanoparticles by two step desolvation–a new preparation method, surface modifications and cell uptake. J Microencapsul, 17, 187–193.
   PubMed Web of Science ®Google Scholar
• Cummings J, Willmott N, Marley E, Smyth J. (1991). Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition. Biochem Pharmacol, 41, 1849–1854.
   PubMed Web of Science ®Google Scholar
• Fiete D, Baenziger JU. (1997). Isolation of the SO4-4-GalNAcbeta1,4GlcNAcbeta1,2Manalpha-specific receptor from rat liver. J Biol Chem, 272, 14629–14637.
   PubMedGoogle Scholar
• Fiete D, Srivastava V, Hindsgaul O, Baenziger JU. (1991). A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1,4GlcNAc beta 1,2Man alpha that mediates rapid clearance of lutropin. Cell, 67, 1103–1110.
   PubMed Web of Science ®Google Scholar
• Fiete DJ, Beranek MC, Baenziger JU. (1998). A cysteine-rich domain of the “mannose” receptor mediates GalNAc-4-SO4 binding. Proc Natl Acad Sci USA, 95, 2089–2093.
   PubMed Web of Science ®Google Scholar
• Gupta GK, Kansal S, Misra P, Dube A, Mishra PR. (2009). Uptake of biodegradable gel-assisted LBL nanomatrix by Leishmania donovani-infected macrophages. AAPS PharmSciTech, 10, 1343–1347.
   PubMed Web of Science ®Google Scholar
• Hallab NJ, Bundy KJ, O’Connor K, Clark R, Moses RL. (1995). Cell adhesion to biomaterials: correlations between surface charge, surface roughness, adsorbed protein, and cell morphology. J Long Term Eff Med Implants, 5, 209–231.
   PubMed Web of Science ®Google Scholar
• Hans ML, Lowman AM. (2002). Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid St M, 6, 319–327.
   Web of Science ®Google Scholar
• Harris N, Super M, Rits M, Chang G, Ezekowitz RA. (1992). Characterization of the murine macrophage mannose receptor: demonstration that the downregulation of receptor expression mediated by interferon-gamma occurs at the level of transcription. Blood, 80, 2363–2373.
   PubMed Web of Science ®Google Scholar
• Hartmann G, Vassileva V, Piquette-Miller M. (2005). Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. Drug Metab Dispos, 33, 820–828.
   PubMed Web of Science ®Google Scholar
• Jahanshahi M, Sanati MH, Hajizadeh S, Babaei Z. (2008). Gelatin nanoparticle fabrication and optimization of the particle size. Physica Status Solidi (a), 205, 2898–2902.
   Web of Science ®Google Scholar
• Jain SK, Gupta Y, Jain A, Saxena AR, Khare P, Jain A. (2008). Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine, 4, 41–48.
   PubMed Web of Science ®Google Scholar
• Jameela SR, Jayakrishnan A. (1995). Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials, 16, 769–775.
   PubMed Web of Science ®Google Scholar
• Kansal S, Tandon R, Dwivedi P, Misra P, Verma PR, Dube A, Mishra PR. (2012). Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. J Antimicrob Chemother. DOI: 10.1093/jac/dks286.
   Google Scholar
• Kaul G, Amiji M. (2002). Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res, 19, 1061–1067.
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Amiji M. (2007). Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine, 3, 32–42.
   PubMed Web of Science ®Google Scholar
• Leo E, Cameroni R, Forni F. (1999). Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates. Int J Pharm, 180, 23–30.
   PubMed Web of Science ®Google Scholar
• Leteux C, Chai W, Loveless RW, Yuen CT, Uhlin-Hansen L, Combarnous Y, Jankovic M, Maric SC, Misulovin Z, Nussenzweig MC, Feizi T. (2000). The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group Lewis(a) and Lewis(x) types in addition to the sulfated N-glycans of lutropin. J Exp Med, 191, 1117–1126.
   PubMed Web of Science ®Google Scholar
• Liu J, Teng L, Liu C, Hu L, Wang Y, Liu H, Wang F. (2009). Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by chemical modification with polysaccharide and attenuation effects on radiation-induced inflammatory cytokine expression in vitro. J Drug Target, 17, 216–224.
   PubMed Web of Science ®Google Scholar
• Liu Y, Misulovin Z, Bjorkman PJ. (2001). The molecular mechanism of sulfated carbohydrate recognition by the cysteine-rich domain of mannose receptor. J Mol Biol, 305, 481–490.
   PubMed Web of Science ®Google Scholar
• Marty JJ, Oppenheim RC, Speiser P. (1978). Nanoparticles–a new colloidal drug delivery system. Pharm Acta Helv, 53, 17–23.
   PubMedGoogle Scholar
• Mitchell JP, Roberts KD, Langley J, Koentgen F, Lambert JN. (1999). A direct method for the formation of peptide and carbohydrate dendrimers. Bioorg Med Chem Lett, 9, 2785–2788.
   PubMed Web of Science ®Google Scholar
• Mitra S, Gaur U, Ghosh PC, Maitra AN. (2001). Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release, 74, 317–323.
   PubMed Web of Science ®Google Scholar
• Mishra PR, Al Shaal L, Müller RH, Keck CM. (2009). Production and characterization of Hesperetin nanosuspensions for dermal delivery. Int J Pharm, 371, 182–189.
   PubMed Web of Science ®Google Scholar
• Mosser DM, Brittingham A. (1997). Leishmania, macrophages and complement: a tale of subversion and exploitation. Parasitology, 115 Suppl, S9–23.
   PubMedGoogle Scholar
• Mukhopadhyay A, Basu SK. (2003). Intracellular delivery of drugs to macrophages. Adv Biochem Eng Biotechnol, 84, 183–209.
   PubMedGoogle Scholar
• Nahar M, Dubey V, Mishra D, Mishra PK, Dube A, Jain NK. (2010). In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis. J Drug Target, 18, 93–105.
   PubMed Web of Science ®Google Scholar
• Nimje N, Agarwal A, Saraogi GK, Lariya N, Rai G, Agrawal H, Agrawal GP. (2009). Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J Drug Target, 17, 777–787.
   PubMed Web of Science ®Google Scholar
• Owens DE 3rd, Peppas NA. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 307, 93–102.
   PubMed Web of Science ®Google Scholar
• Phillips R, Svensson M, Aziz N, Maroof A, Brown N, Beattie L, Signoret N, Kaye PM. (2010). Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7. PLoS Pathog, 6, e1000813.
   PubMedGoogle Scholar
• Rettig L, Haen SP, Bittermann AG, von Boehmer L, Curioni A, Krämer SD, Knuth A, Pascolo S. (2010). Particle size and activation threshold: a new dimension of danger signaling. Blood, 115, 4533–4541.
   PubMed Web of Science ®Google Scholar
• Roseman DS, Baenziger JU. (2000). Molecular basis of lutropin recognition by the mannose/GalNAc-4-SO4 receptor. Proc Natl Acad Sci USA, 97, 9949–9954.
   PubMed Web of Science ®Google Scholar
• Saraogi GK, Sharma B, Joshi B, Gupta P, Gupta UD, Jain NK, Agrawal GP. (2011). Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis. J Drug Target, 19, 219–227.
   PubMed Web of Science ®Google Scholar
• Sett R, Basu N, Ghosh AK, Das PK. (1992). Potential of doxorubicin as an antileishmanial agent. J Parasitol, 78, 350–354.
   PubMed Web of Science ®Google Scholar
• Sett R, Sarkar K, Das PK. (1993). Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease. J Infect Dis, 168, 994–999.
   PubMed Web of Science ®Google Scholar
• Shao JY, Hochmuth RM. (1997). The resistance to flow of individual human neutrophils in glass capillary tubes with diameters between 4.65 and 7.75 microns. Microcirculation, 4, 61–74.
   PubMed Web of Science ®Google Scholar
• Shukla P, Gupta G, Singodia D, Shukla R, Verma AK, Dwivedi P, Kansal S, Mishra PR. (2010). Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives. Expert Opin Drug Deliv, 7, 993–1011.
   PubMed Web of Science ®Google Scholar
• Singodia D, Verma A, Verma RK, Mishra PR. (2012). Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery. Nanomedicine, 8, 468–477.
   PubMed Web of Science ®Google Scholar
• Wadhwa MS, Rice KG. (1995). Receptor mediated glycotargeting. J Drug Target, 3, 111–127.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Sung KC, Hu OY, Yeh CH, Fang JY. (2006). Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Release, 115, 140–149.
   PubMed Web of Science ®Google Scholar
• Weber C, Coester C, Kreuter J, Langer K. (2000). Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm, 194, 91–102.
   PubMed Web of Science ®Google Scholar
• Wu Y, Tibrewal N, Birge RB. (2006). Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol, 16, 189–197.
   PubMed Web of Science ®Google Scholar